Anemia, Hemolytic, Congenital Nonspherocytic
"Anemia, Hemolytic, Congenital Nonspherocytic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any one of a group of congenital hemolytic anemias in which there is no abnormal hemoglobin or spherocytosis and in which there is a defect of glycolysis in the erythrocyte. Common causes include deficiencies in GLUCOSE-6-PHOSPHATE ISOMERASE; PYRUVATE KINASE; and GLUCOSE-6-PHOSPHATE DEHYDROGENASE.
MeSH Number(s)
C15.378.071.141.150.100
C16.320.070.100
Concept/Terms
Anemia, Hemolytic, Congenital Nonspherocytic- Anemia, Hemolytic, Congenital Nonspherocytic
- Anemia, Hemolytic Congenital, Nonspherocytic
- Hemolytic Anemia, Congenital Nonspherocytic
- Anemia, Congenital Nonspherocytic Hemolytic
- Congenital Nonspherocytic Hemolytic Anemia
Below are MeSH descriptors whose meaning is more general than "Anemia, Hemolytic, Congenital Nonspherocytic".
- Diseases [C]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Anemia [C15.378.071]
- Anemia, Hemolytic [C15.378.071.141]
- Anemia, Hemolytic, Congenital [C15.378.071.141.150]
- Anemia, Hemolytic, Congenital Nonspherocytic [C15.378.071.141.150.100]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Anemia, Hemolytic, Congenital [C16.320.070]
- Anemia, Hemolytic, Congenital Nonspherocytic [C16.320.070.100]
Below are MeSH descriptors whose meaning is more specific than "Anemia, Hemolytic, Congenital Nonspherocytic".
This graph shows the total number of publications written about "Anemia, Hemolytic, Congenital Nonspherocytic" by people in Harvard Catalyst Profiles by year, and whether "Anemia, Hemolytic, Congenital Nonspherocytic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 6 | 0 | 6 |
| 2019 | 2 | 0 | 2 |
| 2020 | 6 | 0 | 6 |
| 2021 | 2 | 0 | 2 |
Below are the most recent publications written about "Anemia, Hemolytic, Congenital Nonspherocytic" by people in Profiles.
-
Pyruvate kinase deficiency in children. Pediatr Blood Cancer. 2021 09; 68(9):e29148.
-
Comorbidities and complications in adults with pyruvate kinase deficiency. Eur J Haematol. 2021 Apr; 106(4):484-492.
-
Management of pyruvate kinase deficiency in children and adults. Blood. 2020 09 10; 136(11):1241-1249.
-
The variable manifestations of disease in pyruvate kinase deficiency and their management. Haematologica. 2020 09 01; 105(9):2229-2239.
-
Pyruvate kinase deficiency in a newborn with extramedullary hematopoiesis in the skin. Blood. 2020 08 06; 136(6):770.
-
The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency. Br J Haematol. 2021 03; 192(6):1092-1096.
-
Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency. Am J Hematol. 2020 05; 95(5):472-482.
-
Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease-specific assessments. Eur J Haematol. 2020 May; 104(5):427-434.
-
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency. N Engl J Med. 2019 09 05; 381(10):933-944.
-
How we manage patients with pyruvate kinase deficiency. Br J Haematol. 2019 03; 184(5):721-734.